Diagnosis of Acute Leukemia (AL) by Flow Cytometry (FCM) S. Oukid, S. Taoussi, M.T. Abad. Department of Hematology, EHS CAC Blida, Algeria ESH : International.

Slides:



Advertisements
Similar presentations
Edoardo Pescarmona Dipartimento di Medicina Sperimentale
Advertisements

Introduction to Leukemia
Approach to Acute Leukemia
Quality Control in Immunophenotyping Dr. N. Varma Prof. & Head – Hematology Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh.
A Hematology Case Study about Leukemia by Sarah Wycoff
Introduction To Haematological Malignancies
LEUKEMIA—HEMATOLOGY {S1}
ECSI case Fall 2014 Andrea M. Sheehan, MD Associate Professor of Pathology & Immunology Baylor College of Medicine.
Leukemias.
FLOW CYTOMETRY Dr. MOHAMMED H SAIEMA LDAHR KAAU FACULTY OF APPLIED MEDICAL SCIENCES MEDICAL TECHNOLOGY DEPT. 2 ND YEAR MT INSTROMINTATION EXT
MT 417 – Clinical Hematology II Manual/Special Tests Unit
Acute Leukaemia Dr. Soheir Adam, MRCPath Assistant Professor Department of Haematology, KAUH.
Identification and Diagnosis of the Acute Leukemias
Hematologic Malignancies
LEUKEMIAS Dr Mehboob Khan Pathologist
Acute leukemia Aggressive malignant hematopoietic disorders
Acute Myeloid Leukemia
Chronic Leukemia Dr. Rania Alhady Chronic Lymphocytic leukemia (CLL):
Flow Cytometric Abnormalities in Myelodysplastic Syndrome Raida Oudat,MD Consultant Hematopathologist at Princess Iman Research and Laboratory Sciences.
Clinical Characteristics and Treatment Outcome of Childhood Acute Lymphoblastic Leukemia With the t(4;ll) (q21;q23) By Ching-Hon Pui, Lawrence S. Frankel,
Conclusions We have developed a robust, quality controlled, sensitive method for MRD assessment in precursor B cell ALL which can be replicated in a multi.
The acute Leukemias are clonal hematopoietic malignant disease that arise from the malignant T r a n s f o r m a t i o n of an early Hematopoietic stem.
李啟誠, 朱崧肇, 蔡喜修, 許淑敏, 謝馨慧 Michael R. Loken
Pei Lin, MD Department of Hematopathology UT M.D. Anderson Cancer Center, Houston, TX Monitoring of Minimal Residual Disease Principles and Applications.
Introduction To Flow Cytometry By Noha Kamel. Flow cytometry is a method of measuring multiple physical and chemical characteristics of particles by optical.
Acute Myeloid Leukemias Diagnosis in The Light of WHO Revisions And Correlation With Risk Adaptive Management ; Case Discussions Dr. Rania Medhat Seliem.
Lowhigh GSK3  P(S9)GSK3  CD38-APC CD45-Pacific BlueCD123-PE FSC CD34-PE-Cy7 SSC 0.3% A B C (X1000) (X1000) SSC 50.
Myeloproliferative Disorders (MPDs)
4th Year Medical Student KAU
Acute Leukemia Kristine Krafts, M.D..
Hima Darapu, MD Princeton Baptist Medical Center Baptist Health systems Alabama.
Case 297 Guilin Tang and Sa A. Wang Department of Hematopathology UT MD Anderson Cancer Center.
Chronic leukemias أ. م. د. محمد شنين علي العبادي معاون عميد كلية الطب / جامعة كربلاء ورئيس فرع الامراض والطب العدلي M. B. Ch. B. & F. I. C. P.(Hematopathology)
Minimal Residual Disease(MRD) detections by Flow Cytometry in Acute Leukemia 혈액학파트 안 미 숙.
Case 251: Clinical Information Raymond E Felgar, MD, PhD University of Pittsburgh, Pittsburgh, PA 45-year-old man with recent history of shingles, night.
LEUKEMIA Dr. Omar Alshaer. Acute Leukemia.
Case 255 Elizabeth Courville, MD Robert Hasserjian, MD Massachusetts General Hospital Society for Hematopathology/European Association for Haematopathology.
Hematology There are four lectures: 1.Acute leukemias (2 hours). 2.Chronic leukemias (2 hours).
Society for Hematopathology/European Association for Haematopathology 2013 Case Number 208 Erika Moore, MD; Darshan Roy, MD; Patti Cohen, MD; Adam Bagg,
SH/EAHP Workshop 2013 Case 93 Winnie Wu, M.D. Sheeja Pullarkat, M.D.
CASE 411 Jose Gonzalez-Berjon, MD & Tariq Muzzafar, MD UT M.D. Anderson Cancer Center.
ICCS e-Newsletter CSI Fall 2015 Hywyn R. O. Churchill, MD PhD Division of Hematopathology.
Acute Leukemia Kristine Krafts, M.D..
CASE OF THE MONTH Dr Narender Tejwani Consultant ( Hematopathologist)
eCSI case 2 – November 2016 Jyotinder Nain Punia, MD
Discussion and Conclusions Acknowledgements and References
FREQUENCIES AND PHENOTYPIC CHANGES OF DENDRITIC CELLS DURING ACUTE DENGUE VIRAL INFECTION Lertjuthaporn S1, Khowawisetsut L2, Keawvichit R1, Thitilertdecha.
Image 1 Detection of minimal residual disease (MRD) in consecutive bone marrow (BM) samples from a patient with relapse (A) and a patient still in remission.
Figure 2 Percentage of CD19+/CD34+ cells with decreased CD81 median fluorescence intensity (MFI;
Early T-Cell Precursor ALL in 5 Year Old Female
ICCS e-newsletter CSI Sean R McMaster and George Deeb
“Analyses of Pre-therapy Peripheral Immunoscore and Response to
MRD in Myeloma: the Future is Here
Plasmablastic transformation
STUDY ON FEATURES OF CLINIC, BIOCLINIC AND DIAGNOSIS THE SUBTYPE OF ACUTE LEUKEMIA IN VIETTIEP FRIENDSHIP HOSPITAL, Dr: Pham Thi Loc Hematology.
Human Langerhans cells are immature in melanoma sentinel lymph nodes
Chronic Leukemia Kristine Krafts, M.D..
IMMUNOPHENOTYPING LEUKEMIAS AND LYMPHOMAS
by Karthik A. Ganapathi, Danielle M. Townsley, Amy P. Hsu, Diane C
Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment by.
Detection of Trisomy 12 and Rb-Deletion in CD34+ Cells of Patients With B-Cell Chronic Lymphocytic Leukemia by B. Gahn, C. Schäfer, J. Neef, C. Troff,
Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities.
Partial trisomy 21 contributes to T-cell malignancies induced by JAK3-activating mutations in murine models by Paola Rivera-Munoz, Anouchka P. Laurent,
Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapy by Sara Mastaglio, Eric Wong, Travis.
Case study.
Small macrophages are present in early childhood respiratory disease
Feasibility of minimal residual disease studies by multiparametric flow cytometry for acute myeloid leukemia in a developing country by Lorena Lobo de.
CHRONIC LEUKEMIA BY: DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST
Introduction & haematological malignancies
Presentation transcript:

Diagnosis of Acute Leukemia (AL) by Flow Cytometry (FCM) S. Oukid, S. Taoussi, M.T. Abad. Department of Hematology, EHS CAC Blida, Algeria ESH : International conference on AN UPDATE ON THE MANAGEMENT OF HAEMATOLOGICAL MALIGNANCIES Hammamet, Tunisia – October 28 –

Objectives A major application of flow cytometry in hematology is to characterize the malignant cells in acute leukemia for diagnosis, therapeutic decision and assessment of prognosis.

Introduction Flow cytometry has been introduced in our laboratory since 03 years we analyze : - Chronic lymphoproliferative disorders - Acute Leukemia - Non-Hodgkin Lymphoma : on fine needle aspiration of lymph nodes and trituration after biobsy - PHN Acquisition and analysis by flow cytometry on a BD Facs Calibur 4 colors.

Study Methods - We report results of 142 cases of AL. - Study of the cytologic blood smear and bone marrow. - Samples for CMF - Blood - Bone Marrow - Immunophenotyping using a panel of monoclonal Antibody broad targeting: * Myeloid populations * B Lymphoid populations * T Lymphoid populations Classification by EGIL score to determine the lines B, T, myeloid and biphenotypic

Materials : 142 cases Sex /Age : Children : 44 cases (30,9%) Sex ratio : 0,83 (M= 20/ W=24). average age : 08 years (03 days - 15 years). Adults : 98 cases (69%) Sex ratio : 1,72 (M=62/ W=36). average age : 43,1 years (16 – 82).

Study materials 1 – Samples for FCM : - Blood sample : 54 cases (38%) - Bone marrow sample : 88 cases (62%) 2 - Filtration of Bone Marrow 3 - Count : GB : /mm3 ( ) 4 - Dilution: If GB > /mm3 5 - Sample preparation (FITC, PE, PerCP Cy5.5, APC) 6 - Acquisition 7 - Analysis: - FSC/ SSC - Determining the negative zone - Gating : CD 45 - Analysis of various fluorochromes positivity and intensity.

Results of FCM : 04 Groups : * ALL : 60 cases (42,3%) * AML : 76 cases ( 53,5%) * Biphénotypic AL : 06cases (4,2%) * A L undifferentiated : 05 cas

Results of FCM Group 01 : ALL : 60 cases Children Adults Total ALL B 16 (50%) 16 (50%) 32 (53,4%) ALL T 13 (46,4%) 15 (53,6%) 28 (46,6%) Total 29 (48,4%) 31 (51,6) 60

Children : ALL B : 16 cases Results of FCM 1 : ALL T : 13 cases ALL : 60 cases Adults : ALL B : 16 cases AL L T : 15 cases

Comparison of frequencies of different ALL subtypes (%) with literature Ref Pro B % Common % Pre B % B % ALL T % Children Adults Children AdultsChildren Adults Children Adults Children Adults Ludwig CPMC Alger ,3 7,52,7 7, ,5 44 Blida 60 3,4 3,2 31,2 16,2 20, ,2 44,848,4

Percentage of ALL T in different countries

Results FCM 2 : Children : 12 cases (16%) AML : 76 cases Adults : 64 cases (84%)

AML : AML3 : FISH : t (15 ; 17) observed in 03/04 studied Children Adults Blida (12)CPMC (12) Blida (64)CPMC (68) LAM LAM LAM LAM LAM LAM LAM LAM LAM 00 82

Frequency of different markers in AML Our series TUNISIA Dr E.GOUIDER BELHADJALI Literature MPO 73%93%75-85% CD13 76%80%70-95% CD33 89%67%70-90% CD15 58%42% CD117 45%39%75% HLA Dr 66%68%70-80% CD34 62%49%60%

Résults of FCM 3 Biphénotypic LA : - 03 Children - 03 Adults Cases N° 2 : karyotype and FISH : Philadelphia chromosome positive. Cases N° 5 : karyotype and FISH : trisomy 21. CasesAge Cytological FCM AM L ALL T ALL B 1 12 LAM4 /M5LAM2 + LAL T5,54,5 217 LALAM + LAL B LALAM + LALT3, MDS T LALAL B + LAL T4,54 53 J LALAM + LAL T LALAM5 + LAL B34

F CM : ALL Pre B

FCM : AL L T cortical

Conclusions Recently introduced into our environment, FCM has been a major contribution to the diagnosis of AL and it usefully complements the cytological and cytochemical traditionally existing in our laboratory and was often decisive in the statement of the type of AL and thus the therapeutic orientation.

References : 1 Flow Cytometry in Hematopathology A Visual Approach to Data Analysisand Interpretation Doyen Nguyen, MD Lawrence W. Diamond, MD Raul C. Braylan, MD. 2 British Committee for Standards in Haematology, Revised guidelines for immunophenotyping of acute leukemia and chronic lymphoproliferative disorders, Clin. Lab. Haematol., 24, 1–13, Immunophénotypage des hémopathies malignes Bernard Husson Centres Hospitaliers Jolimont – Lobbes Site de Jolimont Laboratoire de Biologie Clinique - Département Hématologie Unité de CMF 7100 – Haine-Saint-Paul. 4 Hematopathology : Farmarz Naeim et Col 5 Ludwig W. D ; Reiter. A, Loffler. H, and al Immunophenotypic Features of childhood and Adult Acute lymphoblastic Leukemia ( ALL) : Experience of the German Multicentre Trials ALL – BFM and GMALL Leukemia and lymphoma, 1994, Vol 13, Supp 1, pp 71 – Trabzi – Azeli Anissa Application de l’immunophénotypage à la classification des leucémies aigues These pour le diplôme de docteur en science médicales Juillet 1999, Faculté de Médecine d’Alger.